Repligen (RGEN) Enters Exclusive Licensing Agreement w/ Pfizer (PFE) for SMA Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. OSIS
8. BJ
9. NTES
10. DE

Go back to Repligen (RGEN) Enters Exclusive Licensing Agreement w/ Pfizer (PFE) for SMA Program
Pfizer Inc. (NYSE: PFE) Delayed: 28.38 +0.59 (2.12%)
Previous Close $27.79    52 Week High $37.39 
Open $27.77    52 Week Low $28.25 
Day High $28.38    P/E 17.20 
Day Low $27.66    EPS $1.65 
Volume 9,354,335       

Repligen Corp (NASDAQ: RGEN) Delayed: 177.83 -2.46 (1.36%)
Previous Close $180.29    52 Week High $33.79 
Open $179.66    52 Week Low $20.07 
Day High $180.94    P/E 254.04 
Day Low $175.75    EPS $0.70 
Volume 138,211